Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

C. Allison Stewart, Pan Tong, Robert J. Cardnell, Triparna Sen, Lerong Li, Carl M. Gay, Fatemah Masrorpour, You Fan, Rasha O. Bara, Ying Feng, Yuanbin Ru, Junya Fujimoto, Samrat T. Kundu, Leonard E. Post, Karen Yu, Yuqiao Shen, Bonnie S. Glisson, Ignacio Wistuba, John V. Heymach, Don L. GibbonsJing Wang, Lauren Averett Byers

Research output: Contribution to journal › Article › peer-review

144 Scopus citations

Fingerprint

Dive into the research topics of 'Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences